These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28185791)

  • 1. Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade.
    Sung MR; Patel MV; Djalalov S; Le LW; Shepherd FA; Burkes RL; Feld R; Lin S; Tudor R; Leighl NB
    Clin Lung Cancer; 2017 May; 18(3):274-280.e6. PubMed ID: 28185791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
    Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC
    J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What bothers lung cancer patients the most? A prospective, longitudinal electronic patient-reported outcomes study in advanced non-small cell lung cancer.
    LeBlanc TW; Nickolich M; Rushing CN; Samsa GP; Locke SC; Abernethy AP
    Support Care Cancer; 2015 Dec; 23(12):3455-63. PubMed ID: 25791391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer.
    Tanaka K; Akechi T; Okuyama T; Nishiwaki Y; Uchitomi Y
    J Pain Symptom Manage; 2002 May; 23(5):417-23. PubMed ID: 12007759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe symptoms persist for Up to one year after diagnosis of stage I-III lung cancer: An analysis of province-wide patient reported outcomes.
    Hirpara DH; Gupta V; Davis LE; Zhao H; Hallet J; Mahar AL; Sutradhar R; Doherty M; Louie AV; Kidane B; Darling G; Coburn NG
    Lung Cancer; 2020 Apr; 142():80-89. PubMed ID: 32120228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study.
    Weingaertner V; Scheve C; Gerdes V; Schwarz-Eywill M; Prenzel R; Bausewein C; Higginson IJ; Voltz R; Herich L; Simon ST; ;
    J Pain Symptom Manage; 2014 Oct; 48(4):569-81.e1. PubMed ID: 24613784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tailored, supportive care intervention using systematic assessment designed for people with inoperable lung cancer: a randomised controlled trial.
    Schofield P; Ugalde A; Gough K; Reece J; Krishnasamy M; Carey M; Ball D; Aranda S
    Psychooncology; 2013 Nov; 22(11):2445-53. PubMed ID: 23733720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany.
    Iyer S; Taylor-Stokes G; Roughley A
    Lung Cancer; 2013 Aug; 81(2):288-93. PubMed ID: 23561304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: an observational study.
    Mendoza TR; Kehl KL; Bamidele O; Williams LA; Shi Q; Cleeland CS; Simon G
    Support Care Cancer; 2019 Sep; 27(9):3439-3447. PubMed ID: 30661202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors.
    Cheville AL; Novotny PJ; Sloan JA; Basford JR; Wampfler JA; Garces YI; Jatoi A; Yang P
    J Pain Symptom Manage; 2011 Aug; 42(2):213-21. PubMed ID: 21398089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information preferences regarding cure rates and prognosis of Austrian patients with advanced lung cancer.
    Rumpold T; Lütgendorf-Caucig C; Jagsch R; Dieckmann K; Watzke H; Pötter R; Kirchheiner K
    Strahlenther Onkol; 2015 Jul; 191(7):549-56. PubMed ID: 25690939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for follow-up after treatment for lung cancer: assessing the nurse-led option.
    Cox K; Wilson E; Heath L; Collier J; Jones L; Johnston I
    Cancer Nurs; 2006; 29(3):176-87. PubMed ID: 16783116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory Symptoms, Sleep, and Quality of Life in Patients With Advanced Lung Cancer.
    Lou VW; Chen EJ; Jian H; Zhou Z; Zhu J; Li G; He Y
    J Pain Symptom Manage; 2017 Feb; 53(2):250-256.e1. PubMed ID: 27832984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain, fatigue, disturbed sleep and distress comprised a symptom cluster that related to quality of life and functional status of lung cancer surgery patients.
    Lin S; Chen Y; Yang L; Zhou J
    J Clin Nurs; 2013 May; 22(9-10):1281-90. PubMed ID: 23574291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.
    Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data.
    Shallwani SM; Simmonds MJ; Kasymjanova G; Spahija J
    Lung Cancer; 2016 Sep; 99():69-75. PubMed ID: 27565917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The added value of assessing the 'most troublesome' symptom among patients with cancer in the palliative phase.
    Hoekstra J; Vernooij-Dassen MJ; de Vos R; Bindels PJ
    Patient Educ Couns; 2007 Feb; 65(2):223-9. PubMed ID: 16965886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive management of respiratory symptoms in patients with advanced lung cancer.
    McCannon J; Temel J
    J Support Oncol; 2012; 10(1):1-9. PubMed ID: 21996570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative exploration of a respiratory distress symptom cluster in lung cancer: cough, breathlessness and fatigue.
    Molassiotis A; Lowe M; Blackhall F; Lorigan P
    Lung Cancer; 2011 Jan; 71(1):94-102. PubMed ID: 20439127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS).
    Hollen PJ; Gralla RJ; Kris MG; Cox C
    Support Care Cancer; 1994 Jul; 2(4):213-22. PubMed ID: 8087439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.